back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-11-13 09:53 Tx date 2023-11-09 |
$CHGX
CHITOGENX INC |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
56 - Grant of rights
|
$90,000
+500,000 vol $0.18 each |
500,000 | |
| Filed 2023-11-13 09:51 Tx date 2019-06-19 |
$CHGX
CHITOGENX INC |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-28 12:53 Tx date 2023-08-20 |
$CHGX
CHITOGENX INC |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-312,500 vol |
0 | |
| Filed 2023-05-09 15:34 Tx date 2023-05-01 |
$CHGX
CHITOGENX INC |
Laurin, Pierre
4 - Director of Issuer
Holder: Highcue Management Inc. (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
-454,000 vol |
0 | |
| Filed 2023-05-09 15:33 Tx date 2023-05-01 |
$CHGX
CHITOGENX INC |
Laurin, Pierre
4 - Director of Issuer
Holder: Highcue Management Inc. (Indirect Ownership)
|
Convertible Debentures 10%, Exp May 1 2023, $0.20 Conversion Price
38 - Redemption, retraction, cancellation, repurchase
|
-$227,000 vol |
$0 | |
| Filed 2023-05-09 15:32 Tx date 2023-05-04 |
$CHGX
CHITOGENX INC |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+1,692,532 vol |
2,605,432 | |
| Filed 2023-05-09 15:31 Tx date 2023-05-04 |
$CHGX
CHITOGENX INC |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Warrants May 4, 2023 ($0.35) 36mo.
16 - Acquisition or disposition under a prospectus exemption
|
$592,386
+1,692,532 vol $0.35 each |
1,692,532 | |
| Filed 2023-05-09 15:29 Tx date 2019-06-19 |
$CHGX
CHITOGENX INC |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Warrants May 4, 2023 ($0.35) 36mo.
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-08 08:59 Tx date 2022-04-05 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$108,880
+544,400 vol $0.20 each |
912,900 | |
| Filed 2022-04-08 08:57 Tx date 2022-04-05 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Warrants April 5, 2022 ($0.35) 24mo.
16 - Acquisition or disposition under a prospectus exemption
|
+544,400 vol |
544,400 | |
| Filed 2022-04-08 08:53 Tx date 2019-06-19 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Warrants April 5, 2022 ($0.35) 24mo.
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-08 08:51 Tx date 2022-04-05 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$108,800
+544,000 vol $0.20 each |
||
| Filed 2020-12-17 15:14 Tx date 2020-12-17 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,250 vol |
120,250 | |
| Filed 2020-08-23 10:33 Tx date 2020-08-21 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+312,500 vol |
312,500 | |
| Filed 2020-08-23 10:32 Tx date 2020-08-21 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$100,000
+312,500 vol $0.32 each |
368,500 | |
| Filed 2020-05-26 14:04 Tx date 2020-05-22 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,600
+14,000 vol $0.40 each |
56,000 | |
| Filed 2020-05-26 13:08 Tx date 2020-05-21 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,000
+20,000 vol $0.35 each |
42,000 | |
| Filed 2020-05-26 13:08 Tx date 2020-05-21 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,680
+12,000 vol $0.39 each |
22,000 | |
| Filed 2020-05-26 13:07 Tx date 2020-05-21 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,800
+10,000 vol $0.38 each |
10,000 | |
| Filed 2020-05-26 13:06 Tx date 2019-06-19 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-03 16:03 Tx date 2019-12-31 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Holder: Highcue Management Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+204,000 vol |
454,000 | |
| Filed 2020-01-03 16:01 Tx date 2019-10-08 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Holder: Highcue Management Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+250,000 vol |
250,000 | |
| Filed 2020-01-03 16:00 Tx date 2019-06-19 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Holder: Highcue Management Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-03 15:48 Tx date 2019-12-31 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Holder: Highcue Management Inc. (Indirect Ownership)
|
Convertible Debentures 10%, 2 years, $0.30 Conversion Price
16 - Acquisition or disposition under a prospectus exemption
|
$
+$102,000 vol $0.30 each |
$227,000 | |
| Filed 2019-10-11 12:04 Tx date 2019-10-08 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+250,000 vol |
||
| Filed 2019-10-11 10:54 Tx date 2019-10-08 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$125,000
+250,000 vol $0.50 each |
||
| Filed 2019-12-19 11:14 Tx date 2019-10-08 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Holder: Highcue Management Inc. (Indirect Ownership)
|
Convertible Debentures 10%, 2 years, $0.30 Conversion Price
16 - Acquisition or disposition under a prospectus exemption
|
$
+$125,000 vol $0.30 each |
$125,000 | |
| Filed 2019-12-19 11:11 Tx date 2019-06-19 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Holder: Highcue Management Inc. (Indirect Ownership)
|
Convertible Debentures 10%, 2 years, $0.30 Conversion Price
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-11 10:53 Tx date 2019-10-08 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 10%, 2 years, $0.30 Conversion Price
16 - Acquisition or disposition under a prospectus exemption
|
$
+$125,000 vol $0.30 each |
||
| Filed 2019-10-11 12:04 Tx date 2019-10-08 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+250,000 vol |
250,000 | |
| Filed 2019-10-11 10:54 Tx date 2019-10-08 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$125,000
+250,000 vol $0.50 each |
250,000 | |
| Filed 2019-10-11 10:54 Tx date 2019-10-08 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$125,000
+250,000 vol $0.50 each |
||
| Filed 2019-10-11 10:53 Tx date 2019-06-19 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-11 10:53 Tx date 2019-10-08 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 10%, 2 years, $0.30 Conversion Price
16 - Acquisition or disposition under a prospectus exemption
|
$
+$125,000 vol $0.30 each |
$125,000 | |
| Filed 2019-10-11 10:52 Tx date 2019-06-19 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 10%, 2 years, $0.30 Conversion Price
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-23 12:47 Tx date 2019-06-19 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,000
+100,000 vol $0.36 each |
100,000 | |
| Filed 2019-06-23 12:46 Tx date 2019-06-19 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-17 Tx date 2018-12-14 |
$PLI
Prometic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-100,000
-250,000 vol $0.40 each |
2,547,732 | |
| Filed 2018-12-07 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$834,664
+2,140,166 vol $0.39 each |
5,333,319 | |
| Filed 2018-12-07 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,014,998
+1,318,180 vol $0.77 each |
2,797,732 | |
| Filed 2018-03-28 Tx date 2018-03-22 |
$PLI
Prometic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
58 - Expiration of rights
|
$-437,207.67
-255,677 vol $1.71 each |
3,193,153 | |
| Filed 2018-03-10 Tx date 2018-03-01 |
$PLI
Prometic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: InvHealth Holding Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
-8,900,014 vol |
0 | |
| Filed 2018-03-10 Tx date 2018-03-01 |
$PLI
Prometic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: InvHealth Capital Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+8,900,014 vol |
9,394,978 | |
| Filed 2017-12-20 Tx date 2017-11-23 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$3,024,997
+2,130,280 vol $1.42 each |
3,611,591 | |
| Filed 2017-12-20 Tx date 2017-11-23 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$2,199,998
+1,549,295 vol $1.42 each |
||
| Filed 2017-12-08 Tx date 2017-12-04 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$144,619
+84,573 vol $1.71 each |
1,209,640 | |
| Filed 2017-12-08 Tx date 2017-12-04 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-62,185.557
-46,830 vol $1.33 each |
1,162,810 | |
| Filed 2017-12-08 Tx date 2017-12-04 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-70,129.0548
-52,812 vol $1.33 each |
1,188,186 | |
| Filed 2017-12-08 Tx date 2017-12-04 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-144,619.83
-84,573 vol $1.71 each |
2,946,033 | |
| Filed 2017-12-08 Tx date 2017-12-04 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-224,399.56
-78,188 vol $2.87 each |
2,867,845 | |
| Filed 2017-12-08 Tx date 2017-12-04 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$224,399
+78,188 vol $2.87 each |
1,240,998 | |
| Filed 2017-11-28 Tx date 2017-11-23 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$2,199,998
+1,549,295 vol $1.42 each |
3,030,606 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,280,125
+612,500 vol $2.09 each |
1,737,567 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$331,485
+269,500 vol $1.23 each |
1,394,567 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-406,648.55
-269,500 vol $1.51 each |
1,125,067 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$329,912
+192,931 vol $1.71 each |
1,317,998 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-291,113.5859
-192,931 vol $1.51 each |
1,125,067 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$163,199
+56,864 vol $2.87 each |
1,181,931 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-85,802.0896
-56,864 vol $1.51 each |
1,125,067 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-924,201.25
-612,500 vol $1.51 each |
1,125,067 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-331,485
-269,500 vol $1.23 each |
2,343,606 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-329,912.01
-192,931 vol $1.71 each |
2,150,675 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-163,199.68
-56,864 vol $2.87 each |
2,093,811 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-1,280,125
-612,500 vol $2.09 each |
1,481,311 | |
| Filed 2017-09-15 Tx date 2017-09-11 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,000
-100,000 vol $0.12 each |
1,879,552 | |
| Filed 2017-09-15 Tx date 2017-09-13 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-24,000
-200,000 vol $0.12 each |
1,479,552 | |
| Filed 2017-09-15 Tx date 2017-09-12 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-119,970.10
-82,738 vol $1.45 each |
1,007,805 | |
| Filed 2017-09-15 Tx date 2017-09-13 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$24,000
+200,000 vol $0.12 each |
1,207,805 | |
| Filed 2017-09-15 Tx date 2017-09-13 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-119,142.72
-82,738 vol $1.44 each |
1,125,067 | |
| Filed 2017-09-15 Tx date 2017-09-12 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-24,000
-200,000 vol $0.12 each |
1,679,552 | |
| Filed 2017-09-15 Tx date 2017-09-11 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,000
+100,000 vol $0.12 each |
931,970 | |
| Filed 2017-09-15 Tx date 2017-09-11 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-60,069.15
-41,427 vol $1.45 each |
890,543 | |
| Filed 2017-09-15 Tx date 2017-09-12 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$24,000
+200,000 vol $0.12 each |
1,090,543 | |
| Filed 2017-09-12 Tx date 2017-09-07 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,000
+100,000 vol $0.12 each |
873,397 | |
| Filed 2017-09-12 Tx date 2017-09-07 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-60,069.15
-41,427 vol $1.45 each |
831,970 | |
| Filed 2017-09-12 Tx date 2017-09-07 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,000
-100,000 vol $0.12 each |
1,979,552 | |
| Filed 2017-05-23 Tx date 2017-05-18 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$789,692
+381,494 vol $2.07 each |
2,079,552 | |
| Filed 2017-05-16 Tx date 2016-12-31 |
$QBR
Quebecor Inc. |
Laurin, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Unité d'action différée
56 - Grant of rights
|
+1,349 vol |
||
| Filed 2017-05-16 Tx date 2016-12-31 |
$QBR
Quebecor Inc. |
Laurin, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Unité d'action différée
56 - Grant of rights
|
+1,349 vol |
27,638 | |
| Filed 2017-04-13 Tx date 2017-04-11 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$1,280,125
+612,500 vol $2.09 each |
2,613,106 | |
| Filed 2017-03-28 Tx date 2017-03-23 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
58 - Expiration of rights
|
$-1,648,815
-1,340,500 vol $1.23 each |
2,000,606 | |
| Filed 2017-02-15 Tx date 2016-12-31 |
$QBR
Quebecor Inc. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Unité d'action différée
56 - Grant of rights
|
+1,349 vol |
27,638 | |
| Filed 2016-12-30 Tx date 2016-12-29 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: InvHealth Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$56,700
+30,000 vol $1.89 each |
494,964 | |
| Filed 2016-11-25 Tx date 2016-11-21 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$228,155
+133,424 vol $1.71 each |
906,821 | |
| Filed 2016-11-25 Tx date 2016-11-21 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-377,589.92
-133,424 vol $2.83 each |
773,397 | |
| Filed 2016-11-25 Tx date 2016-11-21 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-228,155.04
-133,424 vol $1.71 each |
3,341,106 | |
| Filed 2016-11-24 Tx date 2016-11-23 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: InvHealth Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$70,432
+28,400 vol $2.48 each |
443,364 | |
| Filed 2016-11-24 Tx date 2016-11-24 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: InvHealth Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,920
+21,600 vol $2.45 each |
464,964 | |
| Filed 2016-10-16 Tx date 2016-10-11 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$2,039,998
+710,801 vol $2.87 each |
3,474,530 | |
| Filed 2016-09-06 Tx date 2016-09-01 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-70,658.91
-41,321 vol $1.71 each |
||
| Filed 2016-09-06 Tx date 2016-09-01 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-72,368.91
-42,321 vol $1.71 each |
2,763,729 | |
| Filed 2016-09-06 Tx date 2016-09-01 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$72,368
+42,321 vol $1.71 each |
815,718 | |
| Filed 2016-09-06 Tx date 2016-09-01 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-118,075.59
-42,321 vol $2.79 each |
773,397 | |
| Filed 2016-08-31 Tx date 2016-08-29 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-9,000
-60,000 vol $0.15 each |
1,728,058 | |
| Filed 2016-08-31 Tx date 2016-08-29 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$9,000
+60,000 vol $0.15 each |
833,397 | |
| Filed 2016-08-31 Tx date 2016-08-29 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-167,460
-60,000 vol $2.79 each |
773,397 | |
| Filed 2016-08-31 Tx date 2016-08-30 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$4,500
+30,000 vol $0.15 each |
803,397 | |
| Filed 2016-08-31 Tx date 2016-08-30 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-83,550
-30,000 vol $2.79 each |
773,397 | |
| Filed 2016-08-31 Tx date 2016-08-30 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-4,500
-30,000 vol $0.15 each |
1,698,058 | |
| Filed 2016-05-30 Tx date 2016-05-25 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$951,729
+317,243 vol $3.00 each |
1,788,058 | |
| Filed 2016-04-17 Tx date 2016-04-13 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$36,123
+21,125 vol $1.71 each |
785,124 | |
| Filed 2016-04-17 Tx date 2016-04-13 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-36,123.75
-21,125 vol $1.71 each |
2,806,050 | |
| Filed 2016-04-17 Tx date 2016-04-13 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-36,303.2739
-11,727 vol $3.10 each |
773,397 | |
| Filed 2016-02-26 Tx date 2015-12-31 |
$QBR
Quebecor Inc. |
Laurin, Pierre
4 - Director of Issuer
Direct Ownership
|
Unité d'action différée
56 - Grant of rights
|
+1,517 vol |
26,289 | |
| Filed 2016-01-20 Tx date 2016-01-20 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,795
+9,500 vol $2.61 each |
1,700,615 | |
| Filed 2016-01-20 Tx date 2016-01-20 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,240
+2,000 vol $2.62 each |
33,300 | |
| Filed 2016-01-20 Tx date 2016-01-20 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: InvHealth Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,185
+8,500 vol $2.61 each |
414,964 | |
| Filed 2015-12-22 Tx date 2015-12-21 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-36,205.83
-21,173 vol $1.71 each |
2,827,175 | |
| Filed 2015-12-22 Tx date 2015-12-21 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-34,367.591
-10,910 vol $3.15 each |
763,999 | |
| Filed 2015-12-22 Tx date 2015-12-21 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$36,205
+21,173 vol $1.71 each |
774,909 | |
| Filed 2015-12-04 Tx date 2015-12-03 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-774,913.3125
-259,125 vol $2.99 each |
753,736 | |
| Filed 2015-12-04 Tx date 2015-12-03 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-36,123.75
-21,125 vol $1.71 each |
2,848,348 | |
| Filed 2015-12-04 Tx date 2015-12-03 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-292,740
-238,000 vol $1.23 each |
2,869,473 | |
| Filed 2015-12-04 Tx date 2015-12-03 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$36,123
+21,125 vol $1.71 each |
1,012,861 | |
| Filed 2015-12-04 Tx date 2015-12-03 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$292,740
+238,000 vol $1.23 each |
991,736 | |
| Filed 2015-08-28 Tx date 2015-08-25 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$2,033,998
+1,189,473 vol $1.71 each |
3,107,473 | |
| Filed 2015-08-24 Tx date 2015-08-21 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,392
+2,400 vol $1.83 each |
31,300 | |
| Filed 2015-08-24 Tx date 2015-08-21 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,600
+16,000 vol $1.85 each |
1,691,115 | |
| Filed 2015-08-24 Tx date 2015-08-24 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: InvHealth Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$642.00
+400 vol $1.60 each |
406,464 | |
| Filed 2015-08-24 Tx date 2015-08-24 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: InvHealth Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$65,412
+41,400 vol $1.58 each |
406,064 | |
| Filed 2015-07-21 Tx date 2015-07-15 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,084,860
+882,000 vol $1.23 each |
1,635,736 | |
| Filed 2015-07-21 Tx date 2015-07-15 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+882,000 vol |
||
| Filed 2015-07-18 Tx date 2015-07-15 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-1,084,860
-882,000 vol $1.23 each |
1,918,000 | |
| Filed 2015-07-18 Tx date 2015-07-15 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,031,687
-882,000 vol $2.30 each |
753,736 | |
| Filed 2015-07-18 Tx date 2015-07-15 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+882,000 vol |
1,635,736 | |
| Filed 2015-06-12 Tx date 2015-06-08 |
$PLI
ProMetic Life Sciences Inc. |
Laurin, Pierre
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+410,815 vol |
1,470,815 |